ORIC Pharmaceuticals Inc [NASDAQ: ORIC] gained 33.50% on the last trading session, reaching $7.97 price per share at the time.
If compared to the average trading volume of 766.89K shares, ORIC reached a trading volume of 14441505 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about ORIC Pharmaceuticals Inc [ORIC]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ORIC shares is $18.64 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ORIC stock is a recommendation set at 1.08. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wells Fargo have made an estimate for ORIC Pharmaceuticals Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on October 31, 2024. While these analysts kept the previous recommendation, Stifel raised their target price to Buy. The new note on the price target was released on September 06, 2024, representing the official price target for ORIC Pharmaceuticals Inc stock.
The Average True Range (ATR) for ORIC Pharmaceuticals Inc is set at 0.70 The Price to Book ratio for the last quarter was 2.58, with the Price to Cash per share for the same quarter was set at 2.87.
Trading performance analysis for ORIC stock
ORIC Pharmaceuticals Inc [ORIC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 35.78. With this latest performance, ORIC shares gained by 40.94% in over the last four-week period, additionally sinking by -16.89% over the last 6 months – not to mention a drop of -6.78% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ORIC stock in for the last two-week period is set at 71.34, with the RSI for the last a single of trading hit 77.91, and the three-weeks RSI is set at 65.34 for ORIC Pharmaceuticals Inc [ORIC]. The present Moving Average for the last 50 days of trading for this stock 5.53, while it was recorded at 6.40 for the last single week of trading, and 8.39 for the last 200 days.
ORIC Pharmaceuticals Inc [ORIC]: A deeper dive into fundamental analysis
ORIC Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 12.00 and a Current Ratio set at 12.00.
ORIC Pharmaceuticals Inc [ORIC]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ORIC. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for ORIC Pharmaceuticals Inc go to 5.83%.
An analysis of Institutional ownership at ORIC Pharmaceuticals Inc [ORIC]
The top three institutional holders of ORIC stocks are: NEXTECH INVEST LTD. with ownership of 5.29 million shares, which is approximately 7.5136%. FMR LLC, holding 4.92 million shares of the stock with an approximate value of $$34.79 million in ORIC stocks shares; and FMR LLC, currently with $$34.15 million in ORIC stock with ownership which is approximately 6.8671%.
